M-ROXIM 1.5
Composition (Each vial contains):
Cefuroxime Sodium I.P.
(Equivalent to Cefuroxime): 1500 mg
Dosage Form: Sterile Powder for Injection
Route of Administration: Intravenous / Intramuscular
Therapeutic Class: Second-Generation Cephalosporin Antibiotic
M-ROXIM 1.5 is an injectable antibiotic with high strength because it contains Cefuroxime Sodium at a dosage that equals 1500 mg of Cefuroxime. The medication functions as a second-generation cephalosporin, which treats infections that doctors see in patients with both Gram-positive and Gram-negative bacterial infections. The sterile powder needs reconstitution before it becomes available for intravenous or intramuscular administration to achieve effective systemic effects. M-ROXIM 1.5 serves as the primary choice in hospitals for controlling perioperative infections and treating severe bacterial infections, which require immediate treatment. The medication provides both medical professionals with effective empirical and targeted antibiotic treatment options because of its balanced spectrum and clinical reliability.
M-ROXIM 1.5 is an injectable antibiotic with high strength because it contains Cefuroxime Sodium at a dosage that equals 1500 mg of Cefuroxime. The medication functions as a second-generation cephalosporin, which treats infections that doctors see in patients with both Gram-positive and Gram-negative bacterial infections. The sterile powder needs reconstitution before it becomes available for intravenous or intramuscular administration to achieve effective systemic effects. M-ROXIM 1.5 serves as the primary choice in hospitals for controlling perioperative infections and treating severe bacterial infections, which require immediate treatment. The medication provides both medical professionals with effective empirical and targeted antibiotic treatment options because of its balanced spectrum and clinical reliability.
FAQ
Q: Why do healthcare professionals often prefer Cefuroxime for surgical prophylaxis?
A: It promotes tissue penetration and effective coverage against common surgical site pathogens.
Q: What makes M-ROXIM 1.5 differ from first-generation cephalosporins?
A: M-ROXIM 1.5 provides improved Gram-negative coverage while maintaining activity against key Gram-positive bacteria.
Q: Can this injectable be used for empirical therapy?
A: Yes, it is commonly prescribed by healthcare professionals when the infection source is suspected, but microbiological confirmation is pending.
Q: Can I take other medications alongside M-ROXIM 1.5 injection in mixed bacterial infections?
A: It can only be done when a healthcare professional or doctor recommend to take other medication; otherwise, follow the prescription properly for better results.
Q: Does it require dose modification in renal impairment?
A: Yes, dosing adjustments are done based on creatinine clearance levels under medical supervision.
FAQ
Apply for PCD Franchise – Not for Job Queries
Apply for PCD Franchise – Not for Job Queries
